MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Revolutions Medical Corporation (OTCBB: RMCP – News) is pleased to report that it has recently received a notice of allowance through its patent attorney Richard Moseley from the United States Patent and Trademark Office for issuance as a patent for its Rev Vac Safety syringe. This patent will be issued shortly and will be the second US patent protecting its proprietary Rev Vac Safety Syringe. Ron Wheet, CEO of Revolutions Medical states “the timing couldn’t be any better. As we await clearance from the FDA on our pre-market 510k application for our Rev Vac Safety Syringe, we now will have two strong US patents protecting our proprietary technology. In addition, we have also spent the time and money necessary to protect our US patents internationally over the last 6 months. We plan to begin volume manufacturing of our Rev Vac Safety Syringe in the 1st quarter of 2009 and be fully prepared to launch our sales effort upon clearance. We feel that we now have more than ample protection for our proprietary core technology in our auto retractable vacuum safety syringe.”
